Sequences encoding the surface projection glycoprotein of the coronavirus, murine hepatitis virus (MHV), strain JHM, have been cloned into pAT153 using cDNA produced by priming with specific oligonucleotides on infected cell RNA. The regions of three clones pJMS1010, pJS112 and pJS92, which together encompass the surface protein gene have been sequenced by the chain termination method. The sequence of the primary translation product, deduced from the DNA sequence, predicts a polypeptide of 1235 amino acids with a molecular weight of 136600. This polypeptide displays the features characteristic of a group 1 membrane protein; an amino-terminal signal sequence and carboxy-terminal membrane and cytoplasmic domains. There are 21 potential glycosylation sites in the polypeptide and a cysteine-rich region in the vicinity of the transmembrane domain. During maturation proteolytic processing of the polypeptide occurs and at positions 624 to 628 the sequence Arg Arg-Ala-ArgArg is found, which is similar to a number of basic sequences involved in the cleavage of enveloped RNA virus glycoproteins. The fusogenic properties of the MHV surface protein do not appear to correlate with a strongly hydrophobic region at the putative amino terminus of the carboxy-terminat cleavage product.
INTRODUCTION
Coronaviruses are pleomorphic, enveloped viruses which replicate in the cytoplasm of vertebrate cells and are associated with diseases of economic importance (Siddell et al., 1983a) . In the laboratory, the murine hepatitis virus (MHV) has been extensively used for the study of viral pathogenesis, in particular as a component of a model for demyelinating diseases of man Watanabe et al., 1983; Massa et al., 1986) . The MHV genome is a monopartite, positive-stranded RNA of approximately 18 kb. The genome encodes the nucleocapsid (N), membrane (M or El) and surface (S or E2) proteins of the virion, as well as several non-structural proteins (Sturman & Holmes, 1983; Siddell et al., 1983b) .
The MHV S protein is synthesized on membrane-bound ribosomes as a co-translationally Nglycosylated polypeptide with an apparent tool. wt. of 150000 (Niemann et al., 1982; Holmes et al., 1981; Siddell et al., 1981) . The polypeptides synthesized in vitro or in tunicamycin-treated cells have mol. wt. of approximately 120000 (Rottier et al., 1981; Siddell, 1983) . During transport within the cell, oligosaccharides are trimmed and terminal sugars are added, resulting in a 180000 mol. wt. S polypeptide. Shortly before, or at the time of, virus release a proportion of S is cleaved into two approximately 90000 tool. wt. polypeptides, S 1 and $2 (Niemann et al., 1982; Sturman et al., 1985) . $1 and S: (which are also referred to as 90B and 90A; Sturman et al., 1985) cannot be distinguished by SDS-PAGE but can be separated by hydroxyapatite chromatography. It has been shown that S: is acylated . The cleavage of the S polypeptide is a host cell-dependent event (Frana et al., 1985) and activates its cell-fusing ability. The S protein is also responsible for the attachment/infectivity of the MHV virion and some monoclonal hybridoma antibodies which react with the S protein are able to mediate virus neutralization in vitro and passively protect mice against lethal virus challenge in vivo (Collins et al., 1982) .
The organization and expression of the MHV genome has been studied in detail (for reviews, see Holmes, 1985; SiddeU, 1986) (Fig. 1) . Briefly, in MHV-infected cells six subgenomic mRNAs, as well as genome-sized RNA, are produced. These mRNAs form a 3' co-terminal nested set and each also has a common 5' leader sequence of about 70 bases (Lai et al., 1984) . The available evidence suggests that only the information contained within the 'unique' sequences at the 5' end of each mRNA (i.e. those absent from the next smallest RNA) is translated into protein (Siddell, 1986) . The translation of size-fractionated MHV mRNAs has shown that subgenomic mRNA 3 encodes the S protein (Siddell, 1983) .
Previously, we have isolated cDNA clones containing overlapping viral inserts which encompass approximately 4.6 kb at the 3' end of the MHV-JHM genome Pfleiderer et al., 1986) . Using specific oligonucleotide primers we have now isolated two further clones which contain inserts extending to the 5' end of mRNA 3. The regions of the three clones which together contain the MHV S gene (Fig. 1 ) have been completely sequenced on both strands. This sequence, together with the predicted amino acid sequence of the S gene product is presented in this paper.
METHODS
cDNA cloning. The isolation and characterizaton of the plasmid pJMS1010 has been previously described . The growth of Sac(-) cells, the propagation of MHV-JHM stocks and the isolation of polyadenylated RNA from MHV-JHM-infected cells have also been described (Siddell et al., 1980) . The oligonucleotide primers A (3' GTCGACGACCACACGG 5'), B (3' GTGTGGGACATTCGGAT 5') and others were synthesized using the phosphoramidite method on an Applied Biosystems 380 A DNA Synthesizer. cDNA synthesis was carried out using the method of Gubler & Hoffman (1983) with slight modifications. In particular, prior to trailing the double-stranded cDNA with dC residues, potential RNA overhangs were removed by treatment with DNase-free RNase A (10 ~tg/ml) for 8 min at 37 °C. The tailed ds cDNA was cloned into dG-tailed PstI-cleaved pAT153. This material was used to transform Escherichia coil DH1 and selection was made for tetracycline resistance. Clones containing viral inserts were identified by colony hybridization using polynucleotide kinase 32p-labelled, cDNA synthesis primer as probe. The size of viral inserts in plasmids from hybridizing clones was determined by gel electrophoresis of PstI-cleaved DNA. An oligonucleotide (3' GCATGCCTGCGGTTAG 5'), which corresponds to a region near the 5' end of the MHV-JHM mRNA leader was used in hybridizations to identify the plasmid pJS92.
Subcloning in M13. Fragments of the viral inserts contained within pJMS1010, pJSll2 and pJS92 were generated by a variety of restriction enzymes and were cloned either as mixtures or as single fragments (purified by electroelution from either agarose or acrylamide gel) into the M13 vectors mp8, rap9, mpl8 and mpl9. Where necessary, specific clones were identified by hybridization to single-stranded DNA probes generated from characterized M13 clones (O'Hare et al., 1983) .
DNA sequencing. M13 dideoxynucleotide sequencing was carried out using [ct-35S] dATP. The complete sequence was obtained on both strands. To complete the project oligonucleotides complementary to specific MHV sequences were synthesized and used to prime the sequencing reactions. Sequence data were analysed and assembled using the programs of Staden (1982a) .
Southern~Northern analysis. Northern blot analysis of RNA following electrophoresis in 1~ agaroseformaldehyde gels, Southern blot analyses of DNA and nick translations were performed according to Maniatis et al. (1982) .
RESULTS
The position of the MHV sequences contained within the plasmid pJMS1010 has been previously determined by Northern blot and sequence analysis . The viral insert within the plasmid extends from within the M protein gene (which is translated from mRNA 6) to a position approximately 2.6 kb from the 5' end of mRNA 3 (Fig. 1) . A 16-base oligonucleotide, primer A, complementary to a sequence towards the 5' end of the pJMS1010 insert was used to prime cDNA synthesis from infected cell poly(A)-containing RNA. Plasmid pJS112 obtained from this experiment contained a 2.2 kb insert which hybridized in Northern blots to the MHV mRNAs 3, 2 and 1 (data not shown). Sequence analysis confirmed that the 3' end of the insert corresponded to the cDNA synthesis primer. In a second cDNA synthesis experiment a 17-base oligonucleotide, primer B, complementary to a sequence towards the 5' end of the pJS 112 insert was used to obtain the plasmid pJS92, pJS92 contained an insert of 530 bp and hybridized in Northern blot analysis to all viral mRNAs. Hybridization of the pJS92 insert to the cDNA synthesis primer and to a primer corresponding to the MHV-JHM leader sequences (see Methods) was confirmed by Southern blot analysis of PstI-cleaved pJS92 DNA (data not shown). A 3780-base sequence containing the gene encoding the MHV-JHM S propolypeptide (i.e. the predicted primary translation product) is presented in Fig. 2 . Immediately preceding the AUG initiation codon is the sequence UCUAAAC. This sequence is identical to genomic sequences preceding the known or presumed 5' initiation codons of mRNAs 7, 5 and 4 and differs by only one base from the sequence UCCAAAC, preceding the initiation codon of mRNA 6 Pfleiderer et al., 1986) . It is thought that these sequences, referred to as regions of homology, are involved in regulating the synthesis of MHV mRNAs (Armstrong et al., 1984; Spaan et al., 1983) .
The AUG codon at position 31 initiates an open reading frame (ORF) of 3705 bases encoding a polypeptide of 1235 amino acids with a predicted tool. wt. of 136600. This ORF ends with a single UGA termination codon. The sequence context of the initiating codon, AAACA UGC, is frequently found amongst functional eukaryotic initiator sequences (Kozak, 1983) .
A number of structural features of the S propolypeptide are noteworthy. Firstly, within the MHV-S propolypeptide sequence there are 21 potential N-glycosylation sites of the type Asn-XThr/Ser (assuming that X is not Pro) (Fig. 2) . The distribution of these sites is also shown in Fig.  3 . It is clear that at least one cluster of potential glycosylation sites occurs in the carboxyterminal region of the polypeptide, between amino acids 1092 and 1158. Secondly, a hydropathicity plot of the amino acid sequence of the S propolypeptide, determined using the procedure of Kyte & Doolittle (1982) , reveals two regions of striking hydrophobicity (Fig. 3) . At the amino terminus, the initiator methionine is followed by nine non-polar amino acids and this hydrophobic core precedes a number of small neutral residues (e.g. Ser-11 Gly-14) which are characteristically found at the signal peptidase recognition site (Fig. 2) (Von Heijne, 1984) • At the carboxy terminus of the propolypeptide a sequence of 34 predominantly hydrophobic and neutral amino acids is followed by two positively charged amino acids (Arg-1209, Lys-1210), which are situated 25 amino acids from the carboxy terminus. Moreover, these 'charge cluster' residues are flanked by an unusual distribution of cysteine residues, which constitute 50 % of the residues between positions 1198 to 1215. Not only an unusual distribution, but also a specific sequence, Cys-Gly-Ser-Cys-Cys, is found on either side of the 'charge cluster' (Fig. 2) . Finally, the distribution of charged amino acids in the S propolypeptide (Fig. 3) indicates a particularly striking domain of basic residues, Arg-Arg-Ala-Arg-Arg, at positions 624 to 628.
DISCUSSION
The DNA sequences presented in Fig. 2 encompass the entire 'unique' region of MHV-JHM mRNA 3. In common with the mRNAs for the virion proteins, N and M, the 5' unique region of mRNA 3 is used to encode a single polypeptide, the precursor to the surface protein. In each of the mRNAs encoding MHV virion structural proteins, translation is initiated at the first AUG codon within the mRNA and the expressed ORF does not overlap with any downstream ORF present in the 3' co-terminal sequences. In mRNAs 3, 6 and 7 the initiating codon is found in a preferred context and follows closely (1, 4 and 8 bases respectively) the 'region of homology' sequences which define the 5' ends of the mRNA bodies Pfleiderer et al., 1986) . These data further support the model of a non-overlapping translation strategy for coronavirus gene expression, at least for the virion structural proteins (Siddell, 1986; .
The predicted amino acid sequence of the S propolypeptide, derived from the DNA sequence, reveals several interesting features. The predicted tool. wt. of the S propolypeptide is 136600. This agrees approximately with the size of the polypeptide found in tunicamycin-treated cells or in vitro translation (Siddell, 1983) . If the average mol. wt. of mannose-rich viral glycoprotein carbohydrate side chains is assumed to be 2000 to 3000, it seems likely that a considerable number of the 21 potential glycosylation sites are utilized, in order to account for the approximately 40000 to 50000 apparent mol. wt. difference between the glycosylated and nonglycosylated S polypeptides (Siddell, 1982) .
The hydropathicity analysis indicates that the MHV S polypeptide belongs to the group 1 membrane proteins (Garoff, 1985) . These proteins are inserted across the endoplasmic reticulum membrane starting from their amino terminus using the same mechanism as secretory proteins. They therefore carry a typical amino-terminal hydrophobic signal sequence which is not present in the mature protein. A putative signal sequence is present in the predicted MHV S propolypeptide. The small neutral glycine residue at position 14 appears to be a possible signal peptidase cleavage site (Von Heijne, 1984) .
A second hydrophobic region at the carboxy terminus of the MHV S propolypeptide is characteristic of a transmembrane domain and is delineated from the hydrophilic cytoplasmic domain by the positively charged Arg/Lys residues at positions 1209/1210. Garoff and colleagues have tested the postulate that the hydrophobic transmembrane domain, together with the 'charge cluster' of the cytoplasmic domain make up a membrane binding region of group 1 proteins, which acts as a 'stop transfer signal' to arrest translocation and prevent secretion. Their results, however, indicate that the 'charge cluster' is necessary only for stabilization of the protein-membrane interaction and the hydrophobic stretch alone is able to arrest translocation. Surrounding the charge cluster in the MHV S polypeptide are an unusual number of cysteine residues, which occur in a specific sequence context. It seems possible that these sequences are involved in the acylation of the $2 polypeptide, because acylation of the vesicular stomatitis virus G protein is believed to occur at cysteine residues in the vicinity of the hydrophobic transmembrane domain (Rose et al., 1984; McGee et al., 1984) .
During virus maturation the MHV S polypeptide is cleaved by a host cell enzyme to yield the $1 and $2 polypeptides. The charge analysis of the MHV S polypeptide reveals a sequence ArgArg-Ala-Arg-Arg at positions 624 to 628 which is very similar to a number of basic sequences involved in the cleavage of several other enveloped, RNA virus glycoproteins (White et al., 1983) . Sturman & Holmes (1977) have shown that the MHV-A59 S polypeptide can be cleaved by trypsin and it appears likely that coronaviruses, in common with many enveloped RNA viruses, utilize a cellular trypsin-like endoprotease activity to achieve proteolytic processing. It is not yet known whether a second, carboxypeptidase, enzyme plays a role in the maturation of the coronavirus S protein, as has been shown for the influenza virus haemagglutinin (Garten & Klenk, 1983) .
Following cleavage the fusion properties of the MHV S protein are activated . Examination of the MHV S polypeptide sequence shows that cleavage at the site mentioned above would not result in a strongly hydrophobic domain at the amino terminus of $2. This would contrast with the fusogenic myxovirus proteins, where the hydrophobicity of the amino terminus of, for example, the influenza virus HA2 protein is essential to the fusion process. Possibly, the mechanism of coronavirus-induced cell fusion involves either a less hydrophobic amino-terminal domain on $2 or other, as yet unidentified, hydrophobic domains on the S protein.
Finally, it is of interest to compare the nucleic acid and predicted amino acid sequences of the MHV S protein gene reported here with the recently determined sequence of the avian infectious bronchitis coronavirus (IBV) S protein gene (Binns et al., 1985) . At the nucleic acid level the sequences appear to be essentially unrelated. However, a comparison of the predicted amino acid sequences using the dot matrix program DIAGON (Staden, 1982 b) , which looks not only for identical residues, but also for residues with similar properties, reveals a striking degree of similarity in the $2 polypeptide, but little similarity in the S~ region (Fig. 4) . To some extent the similarities in the $2 region represent recognizable features, for example, the transmembrahe domain, the cysteine-rich region, or the putative cleavage site. Additionally however, there are regions of amino acids with similar properties, and also specific sequences of identical amino acids (for example, the sequence Trp-Pro-Trp-Tyr-Val-Trp-Leu, positions 1184 to 1191 for MHV; 1092 to 1099 for IBV), the significance of which remains to be determined• The cloning and sequencing of the MHV S protein gene is an important step in studies on the molecular biology of MHV and especially the interaction between the virus, the host cell and the immune system during infection. Experiments to investigate these interactions at the molecular level can now be undertaken• We would like to thank Barbara Schelle-Prinz for skilful technical assistance, Helga Kriesinger for typing the manuscript and Professor V. ter Meulen for continuous support• We would also like to thank R. Staden for computer programs. This work was supported by the Deutsche Forschungsgemeinschaft (SFB 165).
